Burel Pharmaceuticals AZUPHEN MB URINARY ANTISEPTIC Capsules, Each capsule contains recall — FDA D-0159-2017
CGMP Deviations; deficiencies at the manufacturer may result in assay or content uniformity failures
Overview of recall records associated with Burel Pharmaceuticals Inc., including dates, categories and classifications where available.
Classification mix: Class II: 6.
CGMP Deviations; deficiencies at the manufacturer may result in assay or content uniformity failures
CGMP Deviations; deficiencies at the manufacturer may result in assay or content uniformity failures
CGMP Deviations; deficiencies at the manufacturer may result in assay or content uniformity failures
CGMP Deviations; deficiencies at the manufacturer may result in assay or content uniformity failures
CGMP Deviations; deficiencies at the manufacturer may result in assay or content uniformity failures
CGMP Deviations; deficiencies at the manufacturer may result in assay or content uniformity failures
This page summarizes recall records in which the official source identifies Burel Pharmaceuticals Inc. as the recalling firm or manufacturer. The number of records should not be treated as a safety rating or a measure of company size, because recall counts depend on product mix, reporting periods and how government records are organized.
Compare the dates, categories and classifications together rather than relying on the total alone. Open an individual record for the recalled product, reason, distribution details and current instructions available from the source.